"bms" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonPharmaceutical research and development pipeline - Bristol Myers Squibb
Pharmaceutical research and development pipeline Bristol Myers Squibb
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B Fierce Biotech
Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myer...
BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma
BMS’ Cobenfy TV ad is latest target of FDA untitled letter spree Fierce Pharma
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour BioSpace
Harbour BioMed and BMS sign multi-specific antibody collab - Pharmaceutical Technology
Harbour BioMed and BMS sign multi-specific antibody collab Pharmaceutical Technology
FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rival - Endpoints News
FDA approves Cytokinetics’ heart drug, giving it an edge over BMS rival Endpoints News
FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos - FirstWord...
FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos FirstWord Pharma
Harbour BioMed inks license deal with BMS - The Pharma Letter
Harbour BioMed inks license deal with BMS The Pharma Letter
Brighton wrestling teams exceling on the mat; BMS girls headed to state - Covington Leader
Brighton wrestling teams exceling on the mat; BMS girls headed to state Covington Leader
Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies - Contract Pharma
Harbour BioMed, BMS Partner to Advance Next-Gen Multi-Specific Antibodies Contract Pharma
BMS Jumps Aboard Harbour’s R&D Ship - Citeline News & Insights
BMS Jumps Aboard Harbour’s R&D Ship Citeline News & Insights
Harbour Biomed closes busy year with $1B+ BMS deal - BioWorld MedTech
Harbour Biomed closes busy year with $1B+ BMS deal BioWorld MedTech
Fujitsu's AIRSTAGE Cloud BMS with v3.1.4 - ACHR News
Fujitsu's AIRSTAGE Cloud BMS with v3.1.4 ACHR News
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) Bristol Myers Squibb
Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy? - BioSpace
Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy? BioSpace
BMS strikes $1.1B multispecific antibody pact with Harbour - FirstWord Pharma
BMS strikes $1.1B multispecific antibody pact with Harbour FirstWord Pharma
Champions in Care - Bristol Myers Squibb
Champions in Care Bristol Myers Squibb
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study BioSpace
CAR T cell therapy patient resources - Bristol Myers Squibb
CAR T cell therapy patient resources Bristol Myers Squibb
Global Inclusion - Bristol Myers Squibb
Global Inclusion Bristol Myers Squibb
Become a business supplier - Bristol Myers Squibb
Become a business supplier Bristol Myers Squibb
Independent research - Bristol Myers Squibb
Independent research Bristol Myers Squibb
Global Patient Week - Bristol Myers Squibb
Global Patient Week Bristol Myers Squibb
About us - Bristol Myers Squibb
About us Bristol Myers Squibb
After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psych...
After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis BioPharma Dive
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis Fierce Pharma
BMS Battery Power Cable - Battery Contection High Temp Wiring Harness with Lug Terminals for Ener...
BMS Battery Power Cable - Battery Contection High Temp Wiring Harness with Lug Terminals for Energy Storage Systems Global Sources
Tri-Cities Airport Ice Rink at Bristol Motor Speedway the Perfect Place for Fun During the Holida...
Tri-Cities Airport Ice Rink at Bristol Motor Speedway the Perfect Place for Fun During the Holidays Speedway Digest
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy - Medical Marketing and Media
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy Medical Marketing and Media
Chris Shibutani, MD - Bristol Myers Squibb
Chris Shibutani, MD Bristol Myers Squibb
Business development leadership team - Bristol Myers Squibb
Business development leadership team Bristol Myers Squibb
Transparency & reporting - Bristol Myers Squibb
Transparency & reporting Bristol Myers Squibb
Our research in neuroscience - Bristol Myers Squibb
Our research in neuroscience Bristol Myers Squibb
Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb
Empowering patients with clarity & confidence through UPL program Bristol Myers Squibb
The Bristol Myers Squibb Foundation - Bristol Myers Squibb
The Bristol Myers Squibb Foundation Bristol Myers Squibb
Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 20...
Harbour inks $90m antibody deal with Bristol Myers Squibb - BioXconomy
Harbour inks $90m antibody deal with Bristol Myers Squibb BioXconomy
Merck, Bristol Myers Squibb plan NJ layoffs (updated) - NJBIZ
BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” - Clinical Trials Arena
BMS delays Alzheimer’s readout for Cobenfy over “site irregularities” Clinical Trials Arena
Driving patient-centric care through global patient outreach - Bristol Myers Squibb
Driving patient-centric care through global patient outreach Bristol Myers Squibb
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it? Bristol Myers Squibb
BMS Group enters Dubai, strikes India partnership in MENA–South Asia push - Insurance Business
BMS Group enters Dubai, strikes India partnership in MENA–South Asia push Insurance Business
Areas of interest - Bristol Myers Squibb
Areas of interest Bristol Myers Squibb
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology - TipRanks
Bristol-Myers Squibb Advances Clinical Trial for BMS-986523 in Oncology TipRanks
BMS lands fourth EU nod for Breyanzi, this time in mantle cell lymphoma - FirstWord Pharma
BMS lands fourth EU nod for Breyanzi, this time in mantle cell lymphoma FirstWord Pharma
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs Bristol Myers Squibb
People and business resource groups - Bristol Myers Squibb
People and business resource groups Bristol Myers Squibb
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line BioSpace
Dhurandhar Box Office 16 BMS Sales: Ranveer Singh's 3rd Saturday Pushes Ranbir Kapoor's Animal Ou...
Clinical trials & studies - Bristol Myers Squibb
Clinical trials & studies Bristol Myers Squibb
From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer - Bristol Myers Squibb
From IMiDs to CELMoDs: Pioneering next generation treatments for blood cancer Bristol Myers Squibb
Psoriasis around the world - Bristol Myers Squibb
Psoriasis around the world Bristol Myers Squibb
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace
Bristol Myers Squibb CEO Chris Boerner says company culture was the missing piece of his ‘patent ...
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future Fierce Biotech
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia Fierce Biotech
APMT, BMS sign Apapa lease through 2031 - Port Technology
APMT, BMS sign Apapa lease through 2031 Port Technology
BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma
BMS, Bain Capital team up on autoimmune-focused newco FirstWord Pharma
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C Bristol Myers Squibb
Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing - Fierce Pharma
Texas files suit against Sanofi, BMS over 'deceptive' Plavix marketing Fierce Pharma
Our science - Bristol Myers Squibb
Our science Bristol Myers Squibb
Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb
Nurse practitioners impact patient care and foster collaboration Bristol Myers Squibb
Honoring oncologists through the Time Back campaign - Bristol Myers Squibb
Honoring oncologists through the Time Back campaign Bristol Myers Squibb
Bristol Myers Squibb wins fifth US approval for CAR T cell therapy Breyanzi - European Pharmaceut...
Bristol Myers Squibb wins fifth US approval for CAR T cell therapy Breyanzi European Pharmaceutical Review
Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma
Merck & Co., BMS to lay off over 300 staffers in New Jersey FirstWord Pharma
Our impact - Bristol Myers Squibb
Our impact Bristol Myers Squibb
Worldwide locations - Bristol Myers Squibb
Worldwide locations Bristol Myers Squibb
Why Bristol-Myers Squibb (BMY) Stock Is Up Today - Yahoo Finance
Why Bristol-Myers Squibb (BMY) Stock Is Up Today Yahoo Finance
BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma nod - Fierce Pharma
BMS scores 5th indication for Breyanzi with FDA marginal zone lymphoma nod Fierce Pharma
Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access...
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to PharmiWeb.com
A global journey through BMS’ R&D hubs - Bristol Myers Squibb
A global journey through BMS’ R&D hubs Bristol Myers Squibb
Pre-approval access to investigational medicines - Bristol Myers Squibb
Pre-approval access to investigational medicines Bristol Myers Squibb
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative ...
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection Bristol Myers Squibb
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial Fierce Biotech
Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies - ge...
Harbour BioMed and Bristol Myers Squibb Partner to Develop Multi-Specific Antibody Therapies geneonline.com
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
BMS expands CAR-T portfolio with $1.5bn Orbital buyout - Pharmaceutical Technology
BMS expands CAR-T portfolio with $1.5bn Orbital buyout Pharmaceutical Technology
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future Fierce Pharma
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel UroToday
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC - BioSpace
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC BioSpace
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
Looking to the Future of Cell Therapy - Bristol Myers Squibb
Looking to the Future of Cell Therapy Bristol Myers Squibb
Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS - Kaseya
Introducing Workforce Planner: Your hub for managing people and projects in Kaseya BMS Kaseya
2025 Annual Meeting of Shareholders - Bristol Myers Squibb
2025 Annual Meeting of Shareholders Bristol Myers Squibb
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO FirstWord Pharma
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech
Annual reports - Bristol Myers Squibb
Annual reports Bristol Myers Squibb
I-See-BMs: Chinese Nuclear Policy Under Xi Jinping - Foreign Policy Research Institute
I-See-BMs: Chinese Nuclear Policy Under Xi Jinping Foreign Policy Research Institute
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm - FirstWord Pharma
BMS ups guidance, but its financial prospects fail to capture investor enthusiasm FirstWord Pharma
Shaping a new era in cancer research - Bristol Myers Squibb
Shaping a new era in cancer research Bristol Myers Squibb
Endocannabinoid signaling and the role of FAAH and MAGL fact sheet - Bristol Myers Squibb
Endocannabinoid signaling and the role of FAAH and MAGL fact sheet Bristol Myers Squibb
FDA Action Alert: BMS, GSK, Amgen and More - BioSpace
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma Fierce Biotech